Does MR-proANP measurement improve risk stratification for mortality and identify cardioembolic etiology or atrial fibrillation in patients after ischemic stroke?
MR-proANP serves as a valuable prognostic biomarker for mortality and helps identify cardioembolic etiology, particularly atrial fibrillation, following ischemic stroke.
MR-proANP is a newly validated blood biomarker providing additional prognostic information for mortality after stroke. Higher MR-proANP levels were associated with cardioembolic stroke etiology and, even more strongly, atrial fibrillation.
Marchis et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: